Pages that link to "Q82288145"

The following pages link to Peptide conjugation at the 5'-end of oligodeoxynucleotides abrogates toll-like receptor 9-mediated immune stimulatory activity (Q82288145):

Displaying 14 items.

• Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification (Q27001592) (← links)
• Immune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses (Q33635971) (← links)
• Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists. (Q34029664) (← links)
• TLR9 Agonist Protects Mice from Radiation-Induced Gastrointestinal Syndrome (Q34125049) (← links)
• Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9. (Q36740874) (← links)
• Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. (Q37377550) (← links)
• DNA-polymer conjugates for immune stimulation through Toll-like receptor 9 mediated pathways (Q37589660) (← links)
• Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy (Q38300025) (← links)
• Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy. (Q46205951) (← links)
• Investigations into the efficacy of multi-component cocaine vaccines. (Q47216341) (← links)
• CpG-PEG Conjugates and their Immune Modulating Effects after Systemic Administration. (Q52676330) (← links)
• Biomaterials for vaccine-based cancer immunotherapy (Q57480337) (← links)
• Cysteinoyl‐ and Cysteine‐containing Dipeptidoylbenzotriazoles with Free Sulfhydryl Groups: Easy Access to N‐terminal and Internal Cysteine Peptides (Q83003651) (← links)
• Comparative Study of 5'- and 3'-Linked CpG-Antigen Conjugates for the Induction of Cellular Immune Responses (Q90332222) (← links)